32 min
TWiPO #107: Discussing the International rEECur Trial for Ewing Sarcoma with Dr. Martin McCabe This Week in Pediatric Oncology
-
- Science
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/Z1D-7i4oy1s
Our host, Dr. Timothy Cripe from Nationwide Children's Hospital, is joined by Dr. Martin McCabe from the University of Manchester to discuss the results of the rEECur trial. The rEECur trial is an international randomized trial conducted on recurrent and primary refractory Ewing sarcoma patients. Dr. McCabe leads a discussion on the genesis of rEECur, what it entailed & what was learned from conducting this trial.
To learn more about this trial, please visit https://www.manchester.ac.uk/discover/news/study-identifies-best-treatment-for-rare-childhood-cancer/
----more----
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org.
Subscribe to TWIPO to get notifications of new uploads.
Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast
WATCH THE VIDEO WEBCAST HERE: https://youtu.be/Z1D-7i4oy1s
Our host, Dr. Timothy Cripe from Nationwide Children's Hospital, is joined by Dr. Martin McCabe from the University of Manchester to discuss the results of the rEECur trial. The rEECur trial is an international randomized trial conducted on recurrent and primary refractory Ewing sarcoma patients. Dr. McCabe leads a discussion on the genesis of rEECur, what it entailed & what was learned from conducting this trial.
To learn more about this trial, please visit https://www.manchester.ac.uk/discover/news/study-identifies-best-treatment-for-rare-childhood-cancer/
----more----
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org.
Subscribe to TWIPO to get notifications of new uploads.
Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast
32 min